Next Article in Journal
Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients
Next Article in Special Issue
Orthotopic Glioblastoma Models for Evaluation of the Clinical Target Volume Concept
Previous Article in Journal
Checkpoint Markers and Tumor Microenvironment: What Do We Know?
Previous Article in Special Issue
Tumor Progression and Treatment-Related Changes: Radiological Diagnosis Challenges for the Evaluation of Post Treated Glioma
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939

by
Anke Brüning-Richardson
1,*,
Gary C. Shaw
1,
Daniel Tams
1,
Tim Brend
1,
Hitesh Sanganee
2,
Simon T. Barry
3,
Gregory Hamm
4,
Richard J. A. Goodwin
4,
John G. Swales
4,
Henry King
1,
Lynette Steele
1,
Ruth Morton
1,
Anastasia Widyadari
1,
Thomas A. Ward
1,
Filomena Esteves
1,
Marjorie Boissinot
1,
Georgia Mavria
1,
Alastair Droop
5,
Sean E. Lawler
6 and
Susan C. Short
1,*
1
Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds LS9 7TF, UK
2
Discovery Sciences BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK
3
Bioscience, Early Oncology, Oncology R&D, AstraZeneca, Cambridge CB2 8PA, UK
4
Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB2 8PA, UK
5
Leeds MRC Medical Bioinformatics Centre, University of Leeds, Leeds LS9 7TF, UK
6
Pathology & Laboratory Medicine, Brown University Cancer Center, Brown University, Providence, RI 02903, USA
*
Authors to whom correspondence should be addressed.
Cancers 2022, 14(15), 3789; https://doi.org/10.3390/cancers14153789
Submission received: 7 June 2022 / Accepted: 27 June 2022 / Published: 4 August 2022
(This article belongs to the Special Issue New Strategies in Diagnosis and Treatments for Brain Tumors)
The authors wish to make the following corrections to this paper [1]:
1. 
Addition of an Author
  • Dr. Georgia Mavria was not included as an author in the original publication, the correct authorship is as below:
Anke Brüning-Richardson 1,*, Gary C. Shaw 1, Daniel Tams 1, Tim Brend 1, Hitesh Sanganee 2, Simon T. Barry 3, Gregory Hamm 4, Richard J. A. Goodwin 4, John G. Swales 4, Henry King 1, Lynette Steele 1, Ruth Morton 1, Anastasia Widyadari 1, Thomas A. Ward 1, Filomena Esteves 1, Marjorie Boissinot 1, Georgia Mavria 1, Alastair Droop 5, Sean E. Lawler 6 and Susan C. Short 1,*
  • The author contribution should also be updated to include GM as below:
Conceptualization, S.C.S. and A.B.-R.; methodology, A.B.-R., G.C.S., D.T., T.B., H.S., S.T.B., G.H., R.J.A.G., J.G.S., H.K., L.S., R.M., A.W., T.A.W., F.E., M.B., A.D., G.M.; software, A.D.; validation, S.C.S., S.E.L.; formal analysis, S.C.S., G.C.S., A.B.-R.; investigation, A.B.-R., G.C.S., D.T., T.B., H.S., S.T.B., G.H., R.J.A.G., J.G.S., H.K., L.S., R.M., A.W., T.A.W., F.E., M.B., A.D.; resources, H.S., S.T.B., G.H., R.J.A.G.; data curation, S.C.S., A.D.; writing—original draft preparation, A.B.-R., S.C.S., S.E.L.; writing—review and editing, S.C.S., S.E.L.; visualization, A.B.-R., S.C.S.; supervision, S.C.S.; project administration, S.C.S.; funding acquisition, S.C.S., A.B.-R. All authors have read and agreed to the published version of the manuscript.
2. 
Email Correction
The correct email address of Susan C. Short is [email protected]
3. 
Text Correction
We have also been alerted to an error in affiliation in the text of the paper: In Section 2.1 Cell lines, sentence 2 and 3: In addition, patient-derived cell lines GBM1 and GBM4 [15] were included in this study. Neural progenitor cells (NP1) and normal human astrocytes (NHA) were obtained from Dr Heiko Wurdak (Leeds Institute of Cancer and Pathology). It should be replaced with the following: The patient-derived tumour models GBM1, GBM4, and the adult human brain progenitor line NP1 were a kind gift from H. Wurdak (Stem Cell and Brain Tumour Group, University of Leeds, Leeds, UK) and were used as previously described in [17,18].
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Reference

  1. Brüning-Richardson, A.; Shaw, G.C.; Tams, D.; Brend, T.; Sanganee, H.; Barry, S.T.; Hamm, G.; Goodwin, R.J.A.; Swales, J.G.; King, H.; et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Brüning-Richardson, A.; Shaw, G.C.; Tams, D.; Brend, T.; Sanganee, H.; Barry, S.T.; Hamm, G.; Goodwin, R.J.A.; Swales, J.G.; King, H.; et al. Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. Cancers 2022, 14, 3789. https://doi.org/10.3390/cancers14153789

AMA Style

Brüning-Richardson A, Shaw GC, Tams D, Brend T, Sanganee H, Barry ST, Hamm G, Goodwin RJA, Swales JG, King H, et al. Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. Cancers. 2022; 14(15):3789. https://doi.org/10.3390/cancers14153789

Chicago/Turabian Style

Brüning-Richardson, Anke, Gary C. Shaw, Daniel Tams, Tim Brend, Hitesh Sanganee, Simon T. Barry, Gregory Hamm, Richard J. A. Goodwin, John G. Swales, Henry King, and et al. 2022. "Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939" Cancers 14, no. 15: 3789. https://doi.org/10.3390/cancers14153789

APA Style

Brüning-Richardson, A., Shaw, G. C., Tams, D., Brend, T., Sanganee, H., Barry, S. T., Hamm, G., Goodwin, R. J. A., Swales, J. G., King, H., Steele, L., Morton, R., Widyadari, A., Ward, T. A., Esteves, F., Boissinot, M., Mavria, G., Droop, A., Lawler, S. E., & Short, S. C. (2022). Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. Cancers, 14(15), 3789. https://doi.org/10.3390/cancers14153789

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop